Arcadia Biosciences to Present at Credit Suisse Small & Mid Cap Conference

DAVIS, Calif. (September 15, 2015) – Arcadia Biosciences, Inc. (NASDAQ: RKDA), an agricultural technology company that develops and commercializes plant traits and products that improve farm economics and benefit the environment and human health, announced that it will participate in the 6th Annual Credit Suisse Small & Mid Cap Conference at the Waldorf Astoria Hotel in New York City. Roger Salameh, Arcadia’s vice president of business development, is scheduled to present at 2:30 p.m. EDT on Thursday, September 17, 2015.

Mr. Salameh and Tom O’Neil, Arcadia’s chief financial officer, will be available for one-on-one meetings with investors throughout the day. Investors attending the conference may schedule a meeting through their representatives at Credit Suisse.

A copy of Arcadia’s latest investor presentation will be provided at the conference and also will be made available in the Investors section of the company’s website.

About Arcadia Biosciences, Inc.
Based in Davis, Calif., with additional facilities in Seattle, Wash. and Phoenix, Ariz., Arcadia Biosciences (NASDAQ: RKDA) develops agricultural products that create added value for farmers while benefitting the environment and enhancing human health. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia’s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. The company was recently listed in the Global Cleantech 100 and was previously named one of MIT Technology Review's 50 Smartest Companies. For more information, visit www.arcadiabio.com.